Bladder infusion
Showing 26 - 50 of >10,000
Precision ofZero Heat Flux Thermometer Versus Pulmonary Artery
Completed
- Zero Heat Flux Thermometer (SpotOnTM) Versus Pulmonary Artery Temperature Measurement in Patients Undergoing On-pump Heart Surgery
- Zero Heat Flux Thermometer
-
Copenhagen, DenmarkRigshospitalet, Copenhagen University Denmark
Feb 12, 2023
Bladder Urothelial Carcinoma, Clear Cell Renal Cell Carcinoma, Malignant Urinary System Tumor Trial in Houston (procedure,
Active, not recruiting
- Bladder Urothelial Carcinoma
- +4 more
- Biopsy
- +4 more
-
Houston, TexasM D Anderson Cancer Center
Jul 18, 2022
Bladder Cancer Trial in Switzerland (Recombinant intravesical BCG (Bacillus Calmette-Guérin VPM1002BC), Atezolizumab, Cisplatin)
Recruiting
- Bladder Cancer
- Recombinant intravesical BCG (Bacillus Calmette-Guérin VPM1002BC)
- +3 more
-
Baden, Switzerland
- +9 more
Aug 12, 2022
Bladder Cancer Trial (Disitamab Vedotin for Injection,Penpulimab Injection)
Not yet recruiting
- Bladder Cancer
- Disitamab Vedotin for Injection,Penpulimab Injection
- (no location specified)
Aug 2, 2022
Urgency Urinary Incontinence Trial in Pittsburgh (Brain functional MRI with simplified urodynamics)
Recruiting
- Urgency Urinary Incontinence
- Brain functional MRI with simplified urodynamics
-
Pittsburgh, PennsylvaniaUniversity of Pittsburgh
Feb 23, 2022
Bladder Cancer Trial (pembrolizumab)
Active, not recruiting
- Bladder Cancer
- Pembrolizumab
- +2 more
- (no location specified)
Oct 11, 2022
Bladder Cancer, Epirubicin Adverse Reaction, Superficial Bladder Cancer Trial in Ankara (Intravesical Solution)
Recruiting
- Bladder Cancer
- +3 more
- Intravesical Solution
-
Ankara, Altindag, TurkeyAnkara Training and Research Hospital
Jul 4, 2022
Urinary Bladder Cancer Trial in München, Ulm, Würzburg (drug, radiation, procedure)
Active, not recruiting
- Urinary Bladder Cancer
- Nivolumab
- +2 more
-
München, Germany
- +2 more
Oct 19, 2022
Locally Advanced or Metastatic Urothelial Carcinoma Trial in United States (Avelumab, Sacituzumab Govitecan, M6223)
Recruiting
- Locally Advanced or Metastatic Urothelial Carcinoma
- Avelumab
- +3 more
-
Coeur d'Alene, Idaho
- +19 more
Oct 4, 2022
Non-Muscle- Invasive Bladder Cancer Trial (Durvalumab, BCG)
Not yet recruiting
- Non-Muscle- Invasive Bladder Cancer
- Durvalumab
- BCG
- (no location specified)
Jul 5, 2023
Multiple Sclerosis, Neurogenic Bladder Trial in Istanbul (Urodynamic Study (Filling cystometry and pressure-flow study),
Recruiting
- Multiple Sclerosis
- Neurogenic Bladder
- Urodynamic Study (Filling cystometry and pressure-flow study)
- +2 more
-
Istanbul, TurkeyKoç University
Oct 16, 2022
Intravenous Infusion of Tramadol-ondansetron on Recovery After
Recruiting
- Post Operative Pain
- +8 more
- Tramadol-ondansetron continuous infusion
- Ropivacaine via epidural catheter
-
Valencia, SpainHospital Universitario La Fe
May 26, 2023
Localized Muscle Invasive Bladder Urothelial Carcinoma, Muscle-Invasive Bladder Carcinoma Trial in Cleveland (Sacituzumab
Not yet recruiting
- Localized Muscle Invasive Bladder Urothelial Carcinoma
- Muscle-Invasive Bladder Carcinoma
- Sacituzumab govitecan
- Adaptive Radiotherapy
-
Cleveland, OhioCleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
Apr 18, 2023
Bladder Cancer Trial in United States (Nivolumab, Nivolumab/Lirilumab)
Completed
- Bladder Cancer
-
Tampa, Florida
- +7 more
Nov 4, 2022
Bladder Adenocarcinoma, Bladder Mixed Adenocarcinoma, Bladder Squamous Cell Carcinoma Trial in Palo Alto (drug, procedure,
Active, not recruiting
- Bladder Adenocarcinoma
- +11 more
- Carboplatin
- +7 more
-
Palo Alto, CaliforniaStanford Cancer Institute Palo Alto
Mar 25, 2022
Bladder Cancer, Breast Cancer, Colorectal Cancer Trial in Baltimore, Bethesda (LMB-9 immunotoxin)
Completed
- Bladder Cancer
- +5 more
- LMB-9 immunotoxin
-
Baltimore, Maryland
- +1 more
Oct 31, 2019
Urgency Urinary Incontinence, Nocturia Trial in Pittsburgh (Mirabegron 50 MG, Brief Behavioral Treatment for Insomnia)
Not yet recruiting
- Urgency Urinary Incontinence
- Nocturia
- Mirabegron 50 MG
- Brief Behavioral Treatment for Insomnia
-
Pittsburgh, PennsylvaniaUniversity of Pittsburgh
Dec 2, 2022
Urothelial Carcinoma, Bladder Cancer Trial in United States (drug, radiation, biological)
Recruiting
- Urothelial Carcinoma
- Bladder Cancer
- Durvalumab (Cohort 1-3)
- +7 more
-
Phoenix, Arizona
- +10 more
Jan 11, 2023
Urogenital Cancer Trial in London (Atezolizumab)
Recruiting
- Urogenital Cancer
-
London, United KingdomBarts and London Hospital NHS Trust
Aug 10, 2022
Carcinoma, Transitional Cell, Urinary Bladder Tumors, Urologic Tumors Trial in Worldwide (enfortumab vedotin (EV),
Active, not recruiting
- Carcinoma, Transitional Cell
- +6 more
- enfortumab vedotin (EV)
- +4 more
-
Anchorage, Alaska
- +105 more
Dec 19, 2022
Advanced Solid Tumor, Platinum-Resistant Ovarian Cancer, Platinum-Resistant Urothelial Carcinoma Trial in Darlinghurst, Kogarah,
Terminated
- Advanced Solid Tumor
- +3 more
- NTX-301
- +2 more
-
Darlinghurst, New South Wales, Australia
- +1 more
Dec 18, 2022
Bladder Urothelial Carcinoma, Stage III Bladder Cancer AJCC v8 Trial in United States (drug, biological, other, radiation)
Recruiting
- Bladder Urothelial Carcinoma
- Stage III Bladder Cancer AJCC v8
- Cisplatin
- +6 more
-
Anchorage, Alaska
- +212 more
Jan 31, 2023
Anesthesia, Anesthesia Complication, Osa Syndrome Trial in Split (Spinal anesthesia with intraoperative dexmedetomidine
Completed
- Anesthesia
- +7 more
- Spinal anesthesia with intraoperative dexmedetomidine sedation
- +3 more
-
Split, CroatiaUniversity Hospital Split
Apr 7, 2022
Urinary Bladder Cancer, Melanoma, Head Neck Cancer Trial in Canada, United States (Autologous genetically modified MAGE-A4?¹º³²T
Active, not recruiting
- Urinary Bladder Cancer
- +9 more
- Autologous genetically modified MAGE-A4ᶜ¹º³²T cells
- Autologous genetically modified MAGE-A4c1032T cells combined with low dose radiation
-
Miami, Florida
- +10 more
Aug 9, 2022